As of May 27
| +0.275 / +2.30%|
The 6 analysts offering 12-month price forecasts for Healthways Inc have a median target of 13.50, with a high estimate of 16.00 and a low estimate of 12.00. The median estimate represents a +10.57% increase from the last price of 12.21.
The current consensus among 9 polled investment analysts is to Buy stock in Healthways Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.